Retatrutide
GLP-1 Class
Purity ≥98.0% — CoA Included
metabolicGLP-1obesity research
GLP-1 Class
Retatrutide
GLP-1/GIP/Glucagon triple receptor agonist. Under active clinical investigation for metabolic research.
$149.99
SKU
OP-RETA-2
Weight
2mg
Purity
≥98.0%
Stock
In Stock
Research Use Only. This compound is not intended for human or veterinary use. It is not approved by the FDA as a drug or medical device. For laboratory and in-vitro research only.
Research Profile
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. It is currently under advanced clinical investigation for metabolic conditions. Research models have been used to study its effects on adipose tissue and glycemic regulation.
Research Applications
- Triple GLP-1/GIP/glucagon receptor agonism research
- Adipose tissue regulation studies
- Glycemic pathway investigation
Storage
Store at -20°C. Protect from light.
Dosage Information
For research use only. Refer to peer-reviewed literature for experimental protocols.